Introduction {#s1}
============

The human gut is colonized by a complex microbial community with a population approximately 3 to 10 times greater than the total number of host cells of which the body consists ([@ILV006C4]). Germ-free (GF) animal studies have shown that gut microbiota and their hosts do not simply coexist, but rather form a mutualistic relationship ([@ILV006C39]). It is now clear that the structure and functions of the gut microbiota play a crucial role in human health through its contributions in fermentation of undigested carbohydrates, vitamin biosynthesis, regulation of energy storage, maturation of the immune system, pathogen colonization resistance, and brain development ([@ILV006C21]; [@ILV006C51]). Alteration in the composition of the gut microbiota has been associated with digestive tract diseases, including necrotizing enterocolitis (NEC) ([@ILV006C55]; [@ILV006C92]) and inflammatory bowel diseases (IBD) ([@ILV006C2]; [@ILV006C57]; [@ILV006C73]; [@ILV006C88]). Additionally, strong evidence from human studies and animal models links intestinal microbiota dysbiosis with a broad-range of immune, metabolic, and neurodevelopmental disorders ([@ILV006C51]), including asthma ([@ILV006C86]), eczema ([@ILV006C30]; [@ILV006C91]), obesity ([@ILV006C46]; [@ILV006C50]; [@ILV006C74]; [@ILV006C84]), and autism ([@ILV006C45]; [@ILV006C62]; [@ILV006C90]).

Defining the mechanistic underpinnings whereby the intestinal microbiota influences human health and disease has been hampered by individual variation in host genetics and microbiota and ethical concerns of using invasive procedures in human subjects, particularly infants and children. Animal models, especially GN rodents, have been extensively employed for exploring the cross talk between the host and commensal bacteria ([@ILV006C12]; [@ILV006C29]; [@ILV006C49]; [@ILV006C80]). Comparative studies of GF and conventional (CV) mice have demonstrated that the gut microbiota profoundly impacts host biology, ranging from intestinal morphology and motility, mucosal and systemic immunity, to absorptive and metabolic functions ([@ILV006C80]). The term CV refers to an animal or human colonized by the microorganisms normally associated with its particular species. For example, GF mice have shorter ileal villi and crypt, and slower rate of small intestinal cell turnover than CV mice ([@ILV006C80]; [@ILV006C96]). Furthermore, GF animals have fewer and smaller Peyer\'s patches and mesenteric lymph nodes and greatly reduced fecal IgA than animals raised under specific pathogen-free (SPF) conditions ([@ILV006C37]; [@ILV006C54]; [@ILV006C68]). Moreover, gene expression profile of mouse ileal epithelium is altered in the absence of commensal bacteria ([@ILV006C38]).

While GN rodent models have provided insight into host--microbe interactions, rodent models are limited by several important physiological and metabolic differences from humans ([@ILV006C31]; [@ILV006C36]). More importantly, many rodent models do not dependably replicate clinical manifestation observed in human diseases ([@ILV006C53]). Therefore, more clinically relevant animal models are needed. Nonhuman primates are good models for humans because they share significant physiological, metabolic, biochemical, and genetic similarity with humans; however, expensive housing, long lifespan, and ethical concerns limit their use ([@ILV006C64]; [@ILV006C75]). The domestic pig (*Sus scrofa*) is closely related to the human in terms of anatomy, physiology, and genetics, and is considered the preferred nonprimate model for humans ([@ILV006C16]; [@ILV006C32]; [@ILV006C56]; [@ILV006C60]). In addition, the piglet is an excellent model for infectious diseases ([@ILV006C56]). The goal of this review is to highlight the usefulness and limitations of the CV pig as a model for human gastrointestinal physiology, immunology, and neurodevelopment. In addition, findings of recent studies using GN and human microbiota-associated (HMA) pigs, and future directions with the model will be discussed.

The Piglet as a Model for Human Physiology, Immunology, and Neurodevelopment {#s2}
============================================================================

Pigs have served as biomedical models for decades. Advantages of the swine model are highlighted in Table [1](#ILV006TB1){ref-type="table"}. Swine have high genome and protein sequence homology with humans, which facilitates understanding of gene--microbiome interactions and the availability of molecular probes and antibodies. For example, when porcine reagents are not available, antibodies and probes directed against human proteins and gene sequences often cross-react with porcine samples ([@ILV006C53]). From a nutritional perspective, pigs and humans are omnivorous, whereas rodents are granivorous. In terms of the gastrointestinal anatomy and physiology, pigs are also more similar to humans than are rodents ([@ILV006C32]; [@ILV006C60]). Also, both pigs and human are colon fermenters, whereas fermentation take place in the cecum of rodents ([@ILV006C36]). Pigs are also immunologically similar to humans. For example, porcine immune responses more closely resemble human responses than mouse responses with \>80% of parameters studied, whereas the immune response in mice was more similar to the human in \<10% of comparisons ([@ILV006C16]). Humans and pigs also share similar brain growth and development patterns. The major brain growth spurt of the pig extends from late prenatal to the early postnatal period, resembling that of the human, which is different from other animals including rats ([@ILV006C19]). Additionally, gross anatomical features such as gyral pattern and gray and white matter distribution of the piglet brain are comparable to those of human infants ([@ILV006C15]). Furthermore, the possiblity of using pigs from the same litter and similar disease progression make the pig an excellent model for human gastrointestinal physiology, immunology, and neural development.

###### 

Advantages of the swine model

  ---------------------------------------------------------------------------------------------------------------------------
  Omnivorous -- nutritional requirement and physiology similar to human
  High genome and protein sequence similarities with human
  Immune system more closely resembles human
  Brain growth and development patterns similar to human
  ○ The major brain growth spurt similar to human
  ○ Gross anatomical features of the brain are comparable to that of human infants
  Body size -- allowing various surgical manipulation and collection of adequate quantity of samples.
  Large litter size (10--12 piglets/litter)
  Similar disease progression
  ○ Metabolic diseases, such as obesity and heart disease
  ○ Infectious diseases (e.g., influenza viruses, rotavirus, *Helicobacter pylori*, and *Neisseria meningitides* infection)
  ---------------------------------------------------------------------------------------------------------------------------

[@ILV006C15]); [@ILV006C19]); [@ILV006C53]); [@ILV006C56])

Due to similarities in immune function, pigs are also an outstanding model for infectious diseases and vaccine development ([@ILV006C56]) and have been used extensively to study infectious diseases relevant to human health, including respiratory (*Bordetella pertussis* \[[@ILV006C23]\], cornona virus \[[@ILV006C70]\], influenza viruses \[[@ILV006C47]\], *Mycobacterium tuberculosis* \[[@ILV006C27]\], *Pseudomonas aeruginosa*, and *Staphylococcus aureus* \[[@ILV006C59]\]) and gastrointestinal pathogens (*Cryptosporidium parvum* \[[@ILV006C87]\], *Helicobacter pylori* \[[@ILV006C58]\], hepatitis E virus \[[@ILV006C48]\], norovirus \[[@ILV006C11]\], and rotavirus \[[@ILV006C71]\]).

Limitations of the Conventional Pig Model {#s3}
=========================================

Conventional piglets are extensively used for studies of early nutrition on gastrointestinal, immune and neural development ([@ILV006C32]; [@ILV006C60]; [@ILV006C69]); however, a major limitation of the CV piglet model is that the gut microbiota of piglets differs from that of human infants. Phyla-level gut bacterial composition of mother-fed or formula-fed (FF) 3-month-old infants ([@ILV006C20]) and 21-day-old piglets (unpublished observations) are compared in Figure [1](#ILV006F1){ref-type="fig"}. While differences between mother-fed or FF neonates of both species can be appreciated, marked differences in the gut microbiota between neonates of the two species exist. For example, Actinobacteria (mainly *Bifidobacterium*) predominates (\>50% of 16S rRNA sequences) in both breastfed (BF) and FF infants, whereas little Actinobacteria (\<0.2% of 16S rRNA sequences) is detectable in piglets. The predominant phyla in both sow-reared (SR) and FF-fed piglets are Bacteroidetes and Firmicutes, which is more similar to the adult human ([@ILV006C50]). Additionally, both SR and FF piglets have greater microbial diversity than human infants. Establishment of the intestinal microbiota after birth plays a vital role in development of the neonatal gastrointestinal and immune systems ([@ILV006C1]; [@ILV006C79]). Recent data have also shed light on the ability of microbiota to influence brain development and behavior ([@ILV006C14]; [@ILV006C17]; [@ILV006C18]). However, differences in the native gut microbiota between the infant and the piglet complicate direct translation of results from piglets to humans. A solution to this problem is to develop piglets harboring a human gut microbiota.

![Mean relative abundances of bacterial phyla within fecal microbiota of 3-month-old infants and 21-day-old piglets. Data were obtained by pyrosequencing of V1-- V3 regions of bacterial 16S rRNA genes. The numbers in parentheses in the figure legends indicate the percentage of total 16S rRNA sequences. Panel: (A) BF infants at 3 months; (B) FF infants at 3 months; (C) SR piglets at 21 days (D) FF piglets at 21 days. Human infant data are from [@ILV006C9]), and piglet data are unpublished. Abbreviations: BF, breast-fed; FF, formula-fed; SR, sow-reared.](ilv00601){#ILV006F1}

Germ-Free and Gnotobiotic Pigs {#s4}
==============================

Gnotobiotic animals are animals colonized with known strains of bacteria or microbiota. They are delivered by cesarean section (or sterile hatching of eggs) under aseptic conditions and are raised within sterile isolators and fed sterile water and food in order to control their exposure to microorganisms ([@ILV006C7]; [@ILV006C33]). Germ-free animals are gnotobiotic animals that have been maintained free from microorganisms, including bacteria, fungi, viruses, and parasites throughout their life. Gnotobiotic experiments take advantages of highly controlled, repeatable experimental design, which reduces interindividual variation. As of the writing of this review, over 500 publications have used GN piglets.

Gnotobiotic pigs have been used to study the impact of bacterial colonization on the host, including organ growth, intestinal morphology, physiology, and immune development (Table [2](#ILV006TB2){ref-type="table"}). Relative to CV pigs, GF pigs have smaller thyroid and liver size, but larger spleen, lung, heart, and gall bladder mass at 7 weeks of age ([@ILV006C78]). [@ILV006C77] investigated the effects of colonization of different bacterial species on small intestinal morphology and observed that the relative length of the small intestine (SI) was smaller in GF and mono-associated (MA) piglets than in CV piglets at postnatal day 13. They also showed that GF and MA piglets had lower relative weights of proximal SI regions than that of CV piglets. This is consistent with previous findings reporting that the SI thickness of GF pigs was lower than CV pigs ([@ILV006C78]). In addition, GF and MA piglets had shorter crypt depths, longer villi height, reduced lamina propria cellularity, and smaller Peyer\'s patches in their SI compared to their CV counterparts ([@ILV006C77]; [@ILV006C94]). The intestinal microbiota also affects brush border enzyme activities. Aminopeptidase N and lactase phlorizin hydrolase activities were lower in SI enterocytes of CV piglets in comparison with piglets maintained GF or mono-associated with nonpathogenic *Escherichia coli* or *Lactobacillus fermentum* at 14 days of age ([@ILV006C95]). Shorter villus height was observed in CV pig enterocytes ([@ILV006C94]), thus the lower enzyme activity in CV pigs may be partly explained by reduced cell maturity or mature cell number. In addition, reduced enzyme activity in CV pigs could be due to microbial brush border enzyme deactivation ([@ILV006C95]).

###### 

Differences in morphology, physiology, and immunology between gnotobiotic and conventional pigs

  Outcome                                                                                                                                                                 Remarks                                                                                                                                                    References
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------
  Organ growth                                                                                                                                                            GF pigs had a smaller thyroid and liver, but larger spleen, lung, heart, and gall bladder than CV at 7 weeks of age.                                       [@ILV006C78]
  Relative SI length & weight                                                                                                                                             In GF and MA pigs, the relative length of SI was reduced compared with CV at postpartum day 13.                                                            [@ILV006C77]
  Compared to GF and MA, relative weight of proximal SI regions was higher for CV; while higher relative weight in the distal regions was reported in GF.                 [@ILV006C77]                                                                                                                                               
  The SI thickness of GF pigs was reduced compared with CV.                                                                                                               [@ILV006C78]                                                                                                                                               
  SI morphology                                                                                                                                                           Relative to CV pigs, GF & MA pigs had short crypt depths and longer villi height.                                                                          [@ILV006C77]; [@ILV006C94]
  GF and MA pigs had reduced lamina propria cellularity; GF had smallest Peyer′s patch, MA intermediate, and CV largest.                                                  [@ILV006C77]                                                                                                                                               
  GF pigs had a slower turnover of SI epithelial cells compared with CV pigs.                                                                                             [@ILV006C78]; [@ILV006C95]                                                                                                                                 
  Brush border enzyme activity                                                                                                                                            Aminopeptidase N and lactase phlorizin hydrolase activities were lower in SI enterocytes of CV pigs in comparison with GF and MA pigs at 14 days of age.   [@ILV006C95]
  Immune development                                                                                                                                                      GF pigs had fewer leukocytes and lower proportion of mature neutrophils in blood at 7 weeks of age.                                                        [@ILV006C78]
  Mono-associated GF pigs with *Escherichia coli* strains increased numbers of dendritic and T cells in diffuse lymphoid tissue of the jejunum 2 days post-association.   [@ILV006C35]                                                                                                                                               
  Serum immunoglobulin level in piglets colonized with a mixture of defined bacteria was significantly higher than in GF piglets in the first 6 weeks of life.            [@ILV006C8]                                                                                                                                                
  SI expression of proinflammatory cytokines IL-1β and IL-6 were higher in GF and MA pigs relative to CV at postnatal day 13.                                             [@ILV006C77]                                                                                                                                               

Abbreviations: CV, conventional; GF, germ-free; MA, mono-associated; SI, small intestine.

Several studies have investigated the role of bacterial colonization on the host immune development. [@ILV006C35] compared the immunological structure of the lamina propria in the jejunum of GF piglets with piglets associated with two strains of commensal *E.coli* between 1 and 4 days of age*.* By two days after transfaunation, they found that mono-association of GF piglets with *E. coli* increased the numbers of dendritic and T cells in diffuse lymphoid tissue of the jejunum. Additionally, SI expression of proinflammatory cytokines interleukin-1β (IL-1β) and IL-6 were higher in GF and MA piglets compared with CV piglets at postnatal day 13 ([@ILV006C77]). Other studies have shown effects on systemic immunity as well; relative to GF piglets, serum immunoglobulin level of piglets colonized with a mixture of defined bacteria was significantly greater on the first 6 weeks of life ([@ILV006C8]).

Gene microarray profiling of the SI epithelium in GF and CV piglets confirmed the essential role of a commensal microbiota for normal development of the host intestinal transcriptome. Genes involved in transcription, cell proliferation and differentiation, nutrient transport and metabolism, xenobiotic metabolism and immune responsiveness were upregulated in GN piglets bearing a microbiota from CV piglets versus GF piglets ([@ILV006C13]).

Despite the fact that GN piglets differ in aspects of gastrointestinal and immune development relative to CV piglets, GN pigs still provide a unique and powerful model for study of enteric diseases that affect both humans and pigs. For example, GN piglets have been used to investigate disease pathogenesis and/or immunity to rotavirus ([@ILV006C71]), enterohemorragic *Escherichia coli* ([@ILV006C6]), *Clostridium difficile* ([@ILV006C82]), and *Shigella dysenteriae* Type I ([@ILV006C43]) infections, among others ([@ILV006C56]). Furthermore, beneficial effects of probiotics ([@ILV006C3]; [@ILV006C52]) and the application of vaccination ([@ILV006C42]) have been tested with GN pig infection models.

The Human Microbiota--Associated (HMA) Pig Model and its Current Application {#s5}
============================================================================

In most GN pig studies, pigs were colonized with single or multiple strains of bacteria. These studies are useful for delineating the physiological functions of specific microbes, but the effects of single or multiple bacteria on the host are not representative of a complex microbiota. Recently, HMA animal models have been developed, both in rodents and pigs. The HMA rodent model has been used to investigate how the gut microbiome is influenced by dietary components and, in turn, influences host health and disease (Gootenberg and Turnbaugh 2011). For example, production of equol from dietary soy isoflavone, the microbial reduction of cholesterol, the effects of a defined diet changes on the gut microbial community structure and functions, and the biogeography and assembly of the gut microbiota have all been studied in HMA rodent models (Gootenberg and Turnbaugh 2011). Additionally, HMA mice have been important for understanding the role of the microbiota in a variety of human diseases (Gootenberg and Turnbaugh 2011), including the biological effects of microbiota obtained from obese adults ([@ILV006C85]) or children with kwashiorkor ([@ILV006C81]). These studies have definitively proven that the clinical signs and symptoms commonly associated with many human diseases could be recapitulated by transferring the microbiome and, in the case of kwashiorkor, providing a similar diet ([@ILV006C81]). However, due to the differences in anatomy and physiology between rodents and humans, some important members of human gut microbiota, such as *Bifidobacterium* do not readily colonize the rodent gut ([@ILV006C66]). Thus, results obtained from the use of rodent models may be difficult to extrapolate to humans, especially human infants, who are extensively colonized with bifidobacterial species.

Several studies have investigated the possibility of transfaunation of gut microbiota from humans to piglets (Table [3](#ILV006TB3){ref-type="table"}). In the study of [@ILV006C61], piglets delivered by cesarean section were housed in an SPF barrier system and were inoculated orally with a fecal suspension collected from a healthy 10-year-old boy. The culture-independent analysis of the gut microbiota of recipient piglets and the human donor revealed that the microbiota of HMA piglet was more similar to that of human donor than to that of CV piglets. Moreover, *Bifidobacterium* and *Bacteroides,* two predominant bacterial groups of the infant gut, were successfully established in the gastrointestinal tract of piglets. Furthermore, introduction of solid food during the weaning period significantly altered the gut microbiota in HMA piglets; this change in the gut microbiota is similar to that observed in human infants (Table [3](#ILV006TB3){ref-type="table"}).

###### 

Studies on the development of human microbiota-associated piglet model

                           [@ILV006C61]                                                                                                          [@ILV006C98]                                                                                                      [@ILV006C97]                                                                                                                                                           
  ------------------------ --------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------- ----------------------------------------------------------------------------- -----------------------------------------------------------------------
  Human donors             10-y-old boy (*n* = 1)                                                                                                Adults (*n* = 10; 50--70 y)                                                                                       3-mo-old BF baby (*n* = 1)                                                               Adults (*n* = 10; 50--70 y)                                                   17--23 d-old BF infant (*n* = 1)
  Fecal inoculation        1 ml of 5% fecal suspension                                                                                           3 ml of 10% fecal suspension                                                                                      3 ml of 10% fecal suspension                                                             3 ml of 10% fecal suspension                                                  1 ml of 5% fecal suspension
  Age inoculated           d 0--2, 4, 6, 8, and 10                                                                                               Once at d 8                                                                                                       Once at d 5 or d 30                                                                      Once at d 23                                                                  d 0--2
  Length of study          35 d                                                                                                                  28 d                                                                                                              15 or 41 d                                                                               36 d                                                                          33 d
  Housing                  SPF system                                                                                                            Sterile isolator                                                                                                  Sterile isolator                                                                         Sterile isolator                                                              Sterile isolator
  Diet                     d 0-18: Piglet formula                                                                                                Infant formula                                                                                                    Infant formula                                                                           d 0-22: Infant formula                                                        Sterile formula
  d 19-35: Infant cereal   d 23-36: Solid porcine diet                                                                                                                                                                                                                                                                                                                                                                                    
  Analytical methods       ERIC-PCR, TTGE, qPCR                                                                                                  Illumina HiSeq                                                                                                    Illumina HiSeq                                                                           Illumina HiSeq                                                                Illumina MiSeq
  Major findings           GN microbiota more closely resembled donor than other humans or CV pigs.Microbial succession was similar to humans.   ↓ diversityLarge UniFrac distance in microbiota between donor and HMA pigs                                        ↓ Proterobacteria↑ FirmicutesMaintain diversityMicrobiota converged toward human donor   ↓ diversityLarge UniFrac distance in microbiota between donor and HMA pigs.   GN pigs carried a microbiota similar to the human donor\'s microbiota
  Conclusions              Transplantation of gut microbiota from human to piglets is feasible.                                                  The pig intestine can be colonized with human fecal microbiota to generate a realistic model of human GI tract.   Human gut microbiota could be transplanted to and colonize GN pigs.                                                                                                    

Abbreviations: BF, breast-fed; CV, conventional; d, day; ERIC-PCR, enterobacterial repetitive intergenic consensus sequence-PCR; GI, gastrointestinal; GN, gnotobiotic; HMA, human microbiota-associated, qPCR, quantitative PCR; SPF, specific pathogen free; TTGE, temperature gradient gel electrophoresis; y, year.

In another study, piglets derived by cesarean section were inoculated with human infant or adult microbiota ([@ILV006C98]) (Table [3](#ILV006TB3){ref-type="table"}). The piglets were housed in sterile isolators and maintained on infant formula or solid diet for swine. High throughput sequencing of the 16S rRNA V6 region was used to monitor to what extent the transplanted human microbiota changed in piglets over time. When infant stool was transferred, the microbiota composition of the HMA piglets converged toward that of the human donor. In contrast, the microbiota of HMA piglets harboring the adult human microbiota did not converge toward the composition of the donor even 20 days post-inoculation. In a more recent study ([@ILV006C97], piglets derived by hysterectomy were inoculated with a suspension of fecal samples obtained from a BF infant between 17 and 23 days postpartum. The piglets were maintained in germ-free isolators and fed sterilized infant formula. Sequencing the V4 region of 16S rRNA genes showed that HMA pigs harbored a microbiota similar to that of the infant donor. Collectively, these studies demonstrate the feasibility of transplantation of a complex human gut microbiota to piglets. Additionally, in comparison with the CV counterparts, the intestinal immunity of HMA piglets is well developed ([@ILV006C10]), whereas that of HMA rodents is not ([@ILV006C41]). Therefore, the HMA piglet model provides a significantly improved system for research on gut ecology and host--microbe interactions, particularly when the human infant is the population of interest ([@ILV006C61]; [@ILV006C98], [@ILV006C97]).

The HMA pig model has been used in several recent publications to study dietary prebiotics and probiotics and for infection models. The first use of HMA piglets was described by [@ILV006C76], who studied the prebiotic activity of short-chain fructo-oligosaccharides (scFOS). The piglets were inoculated with fecal suspension from a 27-year-old man and fed basal diets alone (control) or supplemented with scFOS at 0.5 g/kg body weight daily for 37 days after birth. The composition of the fecal microbiota was monitored by denaturing gradient gel electrophoresis and quantitative polymerase chain reaction (PCR). As demonstrated previously in human trials ([@ILV006C5]; [@ILV006C25]), supplementation of scGOS increased the abundance of *Bifidobacterium*. The bifidogenic effect of GOS (3 g/L of formula) has also been examined in newborn CV piglets; however, no significant increase in fecal bifidobacteria abundance was detected after 15 days of supplementation. Differences in bifidogenic effects of FOS observed in CV and HMA piglets may partly due to differences in *Bifidobacterium* species composition between HMA and CV piglets. For example, HMA piglets harbor *Bifidobacterium* of human origin, such as *B. longum*, *B. breve, B. catenulatum*, and *B. adolescentis,* while *Bifidobacterium* found in the gut of piglets are *B. suis*, *B. globosum*, and *B. pseudolongum* ([@ILV006C34]; [@ILV006C36]). Previous studies have shown prebiotics stimulate bifidobacteria species differently. For example, a mixture of scGOS and polydextrose in infant formula increased *B. longum* but not *B. catenulatum* counts ([@ILV006C72]). Because of the important role of *Bifidobacterium* in preventing intestinal infection, promoting gut integrity, and modulating the host immune homeostasis ([@ILV006C26]), stimulating the growth of gut *Bifidobacterium* is considered as a marker of prebiotic effect ([@ILV006C67]). Therefore, HMA piglets provide a more attractive model than CV piglets for evaluation of potential prebiotics.

Another application of the HMA piglet model is for testing therapeutic interventions, such as probiotics and vaccination on host immune response and gut microbiota. [@ILV006C93] tested dose-dependent effects of *Lactobacillus rhamnosus* GG (LGG) on the immune response to human rotavirus (HRV) vaccination in the HMA pig model. They observed that the human gut microbiota stimulated neonatal immune development, as evidenced by a significant increase in the frequencies of interferon (IFN)-γ producing T cells and a decrease in the frequencies of CD4+CD25-FoxP3+ regulatory T cells (Tregs), and IL-10- or TGF-β-producing Tregs in HRV-vaccinated pigs. Furthermore, the higher dose of LGG (14 doses, up to a 10^9^ colony-forming-unit \[CFU\]/dose), but not the lower dose (9 doses, up to 10^6^ CFU/dose), increased the LGG counts in the intestinal contents of HMA pigs and significantly enhanced HRV-specific IFN-γ-producing T cell responses. Moreover, oral supplementation of LGG prevented the changes in gut microbial composition caused by HRV infection ([@ILV006C97]).

Future Opportunities for the HMA Pig Model {#s6}
==========================================

The HMA Pig Model for Studies of Human Gut Microbiome {#s6a}
-----------------------------------------------------

Because of the important role of human microbiota in the maintenance of health and causation of disease, several international efforts have designed to the study of human microbiota in recent years, including the Human Microbiome Project (HMP) (<http://commonfund.nih.gov/hmp/index> \[[@ILV006C40]\]) and the Metagenomics of the Human Intestinal Tract (MetaHIT) ([www.metahit.eu](www.metahit.eu) \[[@ILV006C65]\]) initiatives. While much progress has been made by describing the composition of the gut microbiome in the human population and linking it to age- and health-related outcomes, much of the data at this point are associative. Furthermore, confounding factors that influence the composition of the gut microbiota are difficult or impossible to control at the present time in human studies. These factors include individual variation in the host genetics and microbiota, current and past environmental exposures, and dietary nutrient composition and caloric load ([@ILV006C29]). The HMA pig model provides the ability to minimize many of the confounding variables mentioned above and, as such, will be valuable for studying microbiota composition change due to external factors, such as age, diet, viral infections, vaccination, and antibiotic use on the development of gut microbiota.

The HMA Pig Model for Investigating the Role of Microbiota on Normal Development {#s6b}
--------------------------------------------------------------------------------

Establishment of the gut microbiota after birth plays an important role in stimulating the development of the neonatal gastrointestinal, immune and neural systems. Studies in GF animals have shown that colonization of the commensal microbiota is required for normal intestinal epithelial cell proliferation and migration, and maintenance of villus morphology ([@ILV006C77]; [@ILV006C94], [@ILV006C95]). GF animals do not develop normal lymph node architecture and have a reduced antibody production ([@ILV006C54]; [@ILV006C68]). Evidence for the role of gut microbiota in neural development is intriguing, and mechanistic data is rapidly emerging. [@ILV006C18] investigated the impact of colonization of gut microbiota on the mammalian brain development and behavior and reported that GF mice displayed increased motor activity and reduced anxiety compared to SPF mice with a normal gut microbiota. Additionally, GF mice exposed to gut microbiota early in life showed characteristics similar to SPF mice, including reduced expression of synaptophysin and PSD-95, two proteins that are specifically involved in synaptogenesis pathways ([@ILV006C18]).

Studies of gastrointestinal, immune, and neural development often require tissue collection from the gastrointestinal tract, immune organs, and brain; however, due to ethical concerns and the limitation of invasive procedure, collecting tissue samples from human subjects is extremely difficult or impossible. Therefore, clinically relevant animal models are needed. Because of the high degree of similarity in anatomy, physiology, immunology, and brain growth and development patterns between pigs and humans, piglets are considered an ideal model for research on gastrointestinal, immune, and brain development. Previous studies have shown environmental factors, such as diet and the use of antibiotics, pre- and probiotics, modify the composition of gut microbiota ([@ILV006C51]). Germ-free piglets colonized with human intestinal communities provide a tool for examining the environmental factors on the establishment of gut microbiota and how the resultant microbiota impacts the development of gastrointestinal, immune, and neural systems.

The HMA Pig Model for Delineating Mechanisms of Microbiota-Associated Diseases {#s6c}
------------------------------------------------------------------------------

As previously discussed, symbiotic host--microbiota interactions play a key role in maintaining homeostasis. Shifts in the bacterial composition of the human gut microbiota have been associated with several human disorders. Table [4](#ILV006TB4){ref-type="table"} summarizes association between gut microbiota change and microbiota-associated diseases. Much of the information regarding the role of gut microbiota in human diseases comes from cross-sectional studies in which microbial community structures are altered in subjects with disease compared to healthy controls. However, it remains unclear whether changes in gut microbiota composition are the cause or the consequence of the diseases. Studies designed to access a causative role for the gut microbiota are critically needed. Understanding dysbiosis in human subjects is challenging because of the extraordinary complexity of the gut ecosystem and the tremendous variability in microbiota between healthy individuals ([@ILV006C28]). HMA pigs provide an excellent model for isolating microbiota as an environmental factor in disease models. For example, fecal samples could be collected from lean and obese humans or individuals suffering from microbiota-associated diseases, such as IBD and NEC, and healthy controls and then used to colonize GF pigs. Using HMA pigs, together with metabolomics, metaproteomics, host gene expression profiling, and metatrascriptomics, we may be able to delineate the role of gut microbiota in diseases at the cellular and molecular level. Using HMA piglets to identify potential biomarkers of microbiota-associated diseases through the use of metabolomics and metaproteomics has implications for development of diagnostic and therapeutic strategies for both infectious and noninfectious conditions. However, a current limitation is the completeness of bioinformatics repositories for metabolomics and proteomics.

###### 

Selected disorders associated with gut microbiota alteration

  Disorders                                                                                    Alteration in gut microbiota                              References
  -------------------------------------------------------------------------------------------- --------------------------------------------------------- --------------
  Asthma                                                                                       ↑ *Clostridum difficile*                                  [@ILV006C63]
  ↑ *Bacteroides fragilis* subgroup and *Clostridium* subcluster XIVa                          [@ILV006C86]                                              
  Eczema                                                                                       ↓ bacterial diversity                                     [@ILV006C91]
  ↑ *Bifidobacterium pseudocatenulatum*, *Esherichia coli* and *Clostridium difficile*         [@ILV006C63];[@ILV006C30]                                 
  Necrotizing enterocolitis                                                                    ↑ γ-proteobacteria and ↓ Firmicutes                       [@ILV006C55]
  ↑ *Citrobacter*- and *Enterococcus*-like sequences                                           [@ILV006C99]                                              
  ↓ bacterial diversity, ↑ γ-proteobacteria                                                    [@ILV006C92]                                              
  Inflammatory bowel diseases                                                                  ↑ γ -proteobacteria, ↓ clostridia in ulcerative colitis   [@ILV006C57]
  ↓ Clostridia,e.g. *Faecalibacterium*, *Bacteroides* and bifidobacteria                       [@ILV006C2];[@ILV006C73]                                  
  ↓ bacterial diversity                                                                        [@ILV006C100]; [@ILV006C88]; [@ILV006C57]                 
  ↓ Firmicutes and ↑ Bacteroidetes                                                             [@ILV006C88]                                              
  Obesity                                                                                      ↓ Bacteroidetes and ↑ Firmicutes                          [@ILV006C50]
  ↑ *Enterobacteriaceae,* ↓*Desulfovibrio* and *Akkermansia muciniphila-*like bacteria         [@ILV006C46]                                              
  ↓ bacterial diversity, ↓ proportion of Bacteroidetes, ↑ proportion of Actinobacteria         [@ILV006C84]                                              
  ↑ Bacteroidetes, ↓ Methanobrevibacter                                                        [@ILV006C74]                                              
  Autism spectrum disorders                                                                    ↑ incidence of the *Clostridium histolyticum* group       [@ILV006C62]
  ↑ *Sutterella* spp. and *Ruminococcus torques*                                               [@ILV006C90]                                              
  ↓ bacterial diversity and ↓ *Prevotella*, *Coprococcus* and unclassified *Veillonellaceae*   [@ILV006C45]                                              

The HMA Pig Model for Studies of Gut Microbiota-Targeted Therapies {#s6d}
------------------------------------------------------------------

Pre-and probiotics have been studied in recent decades as a way to modulate gut microbial composition and functions ([@ILV006C22]). Prebiotics are defined as "a selectively fermented ingredient that results in specific changes, in the composition and/or activity of the gastrointestinal microbiota, thus, conferring benefit(s) upon host health" ([@ILV006C67], p. S2). Prebiotics have the potential to stimulate the growth of beneficial bacteria, such as *Bifidobacterium* and *Lactobacillus*. Probiotics are "live microorganisms which when consumed in adequate amounts, confer a health benefit on the host" ([@ILV006C24], p. 2). *Bifidobacterium* and *Lactobacillus* are the most commonly used probiotics ([@ILV006C89]). Other bacterial genera such as *Akkermansia* and *Faecalibacterium* have also been reported as potential probiotics ([@ILV006C83]). Pre- and/or probiotic intervention has been used successfully for promoting health and prevention or treatment of some microbiota-associated disorders, such as eczema, IBD, NEC, and obesity in human studies ([@ILV006C44]; [@ILV006C51]); however, the mechanisms underlying the beneficial effects of pre- or probiotics remain incompletely understood. Understanding the impact of pre- or probiotics on the gut microbiota and host requires carefully controlled studies in which potential confounding variables such as host genotype, diet, and environmental exposure can be controlled. Gnotobiotic animals can be reared under well-controlled conditions, representing one way to constrain some of these variables. Recently, GN mice harboring a mixture of 15 species of human gut microbiota were studied prior to and after gavage with five fermented milk strains (McNulty et al. 2011). The results revealed only a minimal change in the composition of the microbiota, whereas significant changes in the expression of microbiome-encoded enzymes in numerous metabolic pathways, especially the pathways related to carbohydrate metabolism, were observed (McNulty et al. 2011). Compared to rodents, pigs colonized with human microbiota are more similar to humans in anatomy, physiology, microbiota, and genetics, providing a more attractive model for elucidating molecular bases of pre- and probiotic action.

Conclusions {#s7}
===========

Emerging studies have demonstrated the feasibility of generating and maintaining GN and HMA piglets for relatively long periods of time. These models represent robust systems in which to dissect the intricacies underlying host--microbe relationships essential for maintaining health and preventing disease. To date, studies have not yet exploited HMA piglets as recipients of microbiota associated with specific diseases, as has been effectively exploited in GN rodent models. The HMA piglet is the optimal model for preclinical screening of novel pre-, pro-, and symbiotic preparations and elucidating the impact of these preparations on microbiota composition and host responses.
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